Plasma P-selectin levels are elevated in patients with chronic liver disease

Blood Coagulation and Fibrinolysis

Volumn 14, Issue 4, 2003, Pages 319-325

  Tacke, Frank ^a   Schöffski, Patrick ^a   Trautwein, Christian ^a   Luedde, Tom ^a   Ganser, Arnold ^a   Manns, Michael P ^a   Von Depka, Mario ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

CD62P; Ischaemia reperfusion injury; Liver cirrhosis; P selectin; Platelet activation

Indexed keywords

BLOOD CLOTTING FACTOR; PADGEM PROTEIN; THROMBOMODULIN; THROMBOPLASTIN;

ADULT; AGED; ARTICLE; BLEEDING; CELL INFILTRATION; CHRONIC LIVER DISEASE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENDOTHELIUM INJURY; FEMALE; HUMAN; HUMAN TISSUE; LEUKOCYTE; LEUKOCYTE COUNT; LIVER CIRRHOSIS; LIVER HISTOLOGY; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; THROMBOCYTE COUNT; THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; MALE; MIDDLE AGED; P-SELECTIN; STATISTICS;

EID: 0038509145     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200306000-00001     Document Type: Article

References (31)

1. McEver RP. Leukocyte interactions mediated by selectins. Thromb Haemost 1991; 66:80-87.
2. Furie B, Furie BC, Flaumenhaft R. A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost 2001; 86:214-221.
3. Berger G, Hartwell DW, Wagner DD. P-Selectin and platelet clearance. Blood 1998; 92:4446-4452.
4. Elstad MR, McIntyre TM, Prescott SM, Zimmerman GA. The interaction of leukocytes with platelets in blood coagulation. Curr Opin Hematol 1995; 2:47-54.
5. Subramaniam M, Frenette PS, Saffaripour S, Johnson RC, Hynes RO, Wagner DD. Defects in hemostasis in P-selectin-deficient mice. Blood 1996; 87:1238-1242.
6. Blann AD, Lip GY, Beevers DG, McCollum CN. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers. Thromb Haemost 1997; 77:1077-1080.
7. Leytin V, Mody M, Semple JW, Garvey B, Freedman J. Quantification of platelet activation status by analyzing P-selectin expression. Biochem Biophys Res Commun 2000; 273:565-570.
8. Andre P, Hartwell D, Hrachovinova I, Saffaripour S, Wagner DD. Procoagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 2000; 97:13835-13840.
9. Eppihimer MJ, Schaub RG. P-Selectin-dependent inhibition of thrombosis during venous stasis. Arterioscler Thromb Vasc Biol 2000; 20:2483-2488.
10. Myers DD Jr, Schaub R, Wrobleski SK, Londy FJ III, Fex BA, Chapman AM, et al. P-selectin antagonism causes dose-dependent venous thrombosis inhibition. Thromb Haemost 2001; 85:423-429.
11. McEver RP. P-selectin and PSGL-1: exploiting connections between inflammation and venous thrombosis. Thromb Haemost 2002; 87:364-365.
12. Singh I, Zibari GB, Brown MF, Granger DN, Eppihimer M, Zizzi H, et al. Role of P-selectin expression in hepatic ischemia and reperfusion injury. Clin Transplant 1999; 13:76-82.
13. Martinez-Mier G, Toledo-Pereyra LH, McDuffie JE, Warner RL, Ward PA. P-selectin and chemokine response after liver ischemia and reperfusion. J Am Coll Surg 2000; 191:395-402.
14. Lalor PF, Shields P, Grant A, Adams DH. Recruitment of lymphocytes to the human liver. Immunol Cell Biol 2002; 80:52-64.
15. Peralta C, Fernandez L, Panes J, Prats N, Sans M, Pique JM, et al. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin upregulation in the rat. Hepatology 2001; 33:100-113.
16. Tacke F, Schöffski P, Trautwein C, Manns MP, Ganser A, von Depka M. Tissue factor and thrombomodulin levels are correlated with stage of cirrhosis in patients with liver disease. Blood Coagul Fibrinolysis 2001; 12:539-545.
17. Marcus R, Peritz E, Gabriel KR. On closed testing procedures with special reference to ordered analysis of variance. Biometrika 1976; 63:655-660.
18. Gerok W, Rössle M, Schölmerich J. Liver cirrhosis. In: Gerok W, Blum HE (editors): Hepatology. Munich, Viennna, Baltimore: Urban & Schwarzenberg; 1995. pp. 323-375.
19. Craxi A, Camma C, Giunta M. Clinical aspects of bleeding complications in cirrhotic patients. Blood Coagul Fibrinolysis 2000; 11 (Suppl 1):S75-S79.
20. Rapapod SI. Coagulation problems in liver disease. Blood Coagul Fibrinolysis 2000; 11 (Suppl 1):S69-S74.
21. Violi F, Ferro D, Basili S, Quintarelli C, Saliola M, Alessandri C, et al. Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis. Hepatology 1992; 15:672-676.
22. Blann AD, Noteboom WM, Rosendaal FR. Increased soluble P-Selectin levels following deep venous thrombosis: cause or effect? Br J Haematol 2000; 108:191-193.
23. Frenette PS, Johnson RC, Hynes RO, Wagner DD. Platelets roll on stimulated endothelium in vivo: An interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 1995; 92:7450-7454.
24. Merten M, Thiagarajan P. P-Selectin expression on platelets determines size and stability of platelet aggregates. Circulation 2000; 102:1931-1936.
25. Blann AD, Lip GY. Hypothesis: is soluble P-selectin a new marker of platelet activation? Atherosclerosis 1997; 128:135-138.
26. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res 2001; 89:763-771.
27. Ferroni P, Mammarella A, Martini F, Paoletti V, Cardarello CM, Labbadia G, et al. Increased soluble P-selectin levels in hepatitis C virus-related chronic hepatitis: correlation with viral load. J Investig Med 2001; 49:407-412.
28. Giron-Gonzalez JA, Rodriguez-Ramos C, Elvira J, Galan F, Del Alamo CF, Diaz F, Martin-Herrera L. Serial analysis of serum and ascitic fluid levels of soluble adhesion molecules and chemokines in patients with spontaneous bacterial peritonitis. Clin Exp Immunol 2001; 123:56-61.
29. Panasiuk A, Prokopowicz D, Zak J, Matowicka-Karna J, Osada J, Wysocka J. Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4. Hepatogastroenterology 2001; 48:818-822.
30. Cahill PA, Redmond EM, Sitzmann JV. Endothelial dysfunction in cirrhosis and portal hypertension. Pharmacol Ther 2001; 89:273-293.
31. Shi J, Kokubo Y, Wake K. Expression of P-selectin on hepatic endothelia and platelets promoting neutrophil removal by liver macrophages. Blood 1998; 92:520-528.